Trials / Active Not Recruiting
Active Not RecruitingNCT04511845
A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
A Phase I, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of SPYK04 as Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 113 (estimated)
- Sponsor
- Chugai Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Phase I, open-label, multi-center study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPYK04 | SPYK04 capsule |
Timeline
- Start date
- 2020-09-10
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
- First posted
- 2020-08-13
- Last updated
- 2025-07-14
Locations
15 sites across 2 countries: United States, Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04511845. Inclusion in this directory is not an endorsement.